Andrew Malcolm
About Andrew Malcolm
Andrew Malcolm is a Senior Scientist in Medicinal Chemistry at BenevolentAI in Cambridge, UK, with extensive experience in both academic and industrial settings.
Title
Andrew Malcolm is a Senior Scientist in Medicinal Chemistry currently working at BenevolentAI in Cambridge, England, United Kingdom.
Current Position at BenevolentAI
Andrew Malcolm joined BenevolentAI in May 2020. He holds the position of Senior Scientist in Medicinal Chemistry, where he leverages his extensive experience in both academic and industrial settings to advance medicinal chemistry initiatives.
Past Experience at The Institute of Cancer Research
Prior to joining BenevolentAI, Andrew Malcolm was a Postdoctoral Training Fellow in Medicinal Chemistry at The Institute of Cancer Research in London, United Kingdom. He held this position from 2016 to 2020, gaining valuable experience in cancer-related medicinal chemistry research.
Education and Internships at University of Strathclyde
Andrew Malcolm completed his PhD in Organic Chemistry from the University of Strathclyde between 2012 and 2016. He also earned an MSci in Chemistry with Drug Discovery from the same institution, studying from 2007 to 2012. During his academic tenure, he completed internships in Medicinal Chemistry at Cancer Research UK Beatson Institute in 2012, and at Takeda in Cambridge, United Kingdom, from 2010 to 2011.
Early Career Internships and CASE Internship at GSK
Andrew Malcolm's early career includes a CASE internship at GSK in Stevenage, United Kingdom, in 2015. He also had an internship at the Cancer Research UK Beatson Institute in 2012 and Takeda in Cambridge from 2010 to 2011. These experiences laid a strong foundation for his career in medicinal and organic chemistry.